- Country: Russia
- Summary: Supply of the Drug for Medical Use Sirolimus as Part of the Implementation of the State Program of the Khanty-Mansiysk Autonomous Okrug - Ugra Modern...
- RUT Ref No: 130017114
- Deadline: 19 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: 5030040.00
- Notice Type: Tender
- Document Ref. No.: 0387200009125006102
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of the drug for medical use Sirolimus as part of the implementation of the state program of the Khanty-Mansiysk Autonomous Okrug - Ugra Modern healthcare in 2026
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of the Drug for Medical Use Sirolimus as Part of the Implementation of the State Program of the Khanty-Mansiysk Autonomous Okrug - Ugra Modern... - Russia Tender
The STATE INSTITUTION OF THE KHANTY-MANSI AUTONOMOUS DISTRICT - YUGRA "CENTER FOR DRUG MONITORING, a Government sector organization in Russia, has announced a new tender for Supply of the Drug for Medical Use Sirolimus as Part of the Implementation of the State Program of the Khanty-Mansiysk Autonomous Okrug - Ugra Modern.... This tender is published on RussiaTenders under RUT Ref No: 130017114 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-19.
The estimated tender value is 5030040.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
